JP Morgan Put 270 AMG 21.03.2025/ DE000JK78Y55 /
2025-01-15 8:48:48 AM | Chg.+0.15 | Bid10:32:43 AM | Ask10:32:43 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.30EUR | +13.04% | 1.28 Bid Size: 10,000 |
1.33 Ask Size: 10,000 |
AMGEN INC. DL-... | 270.00 - | 2025-03-21 | Put |
GlobeNewswire
2024-08-29
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
2024-08-28
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
2024-08-15
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
2024-08-12
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2024-08-08
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
2024-08-08
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
2024-08-05
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
2024-08-01
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024